efforts from many corners, the thrombolysis rates are still low, especially in the developing world.[ 2 , 3 ] Although the barriers for thrombolysis are many,[ 4 , 5 ] low acceptance among physicians may be an important factor.[ 6 ] Over-projected bleeding risk and subjective feel of futility[ 7 ] may be significant in this regard.[ 6 ] The clinical decision-making about IVTT varies among physicians.[ 7 , 8 ] The negative role of previous bad patient outcome in subsequent decision-making is well established.[ 9 ] In practice, most physicians remember a few patients who had no improvement (NI) or worsened following an IVTT.
← all excerpts
Real-World Effectiveness of Intravenous Stroke Thrombolysis is more than the Expectation of Practicing Neurologists.
1
—
—